Launching a new corporate entity in an entrenched and crowded marketplace always comes with challenges. When that marketplace is close knit, like the hemophilia community, relationships are strong among all stakeholders—patients, caregivers, and the healthcare professionals who treat them. It’s a small but very engaged group of people all striving to make a better life for themselves.

Our focus on finding the Behavioral and Attitudinal drivers within the market helped differentiate our client, HEMA Biologics, as being uniquely focused on rare bleeding disorders and being aligned with the community’s needs and goals. Based on our analysis, a name, position, core brand elements, corporate personality traits, and the corporate mission were developed to help define HEMA Biologics.